Highly metastatic human prostate cancer growing within the prostate of athymic mice overexpresses vascular endothelial growth factor

Clinical Cancer Research

Volumn 5, Issue 4, 1999, Pages 783-789

  Balbay, M Derya ^a   Pettaway, Curtis A ^a   Kuniyasu, Hiroki ^a   Inoue, Keiji ^a   Ramirez, Edilberto ^a   Li, Emily ^a   Fidler, Isaiah J ^a   Dinney, Colin P N ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; METASTASIS POTENTIAL; MOUSE; NONHUMAN; NUDE MOUSE; PREDICTION; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; TUMOR VASCULARIZATION;

ANIMALS; CARCINOMA; ENDOTHELIAL GROWTH FACTORS; FIBROBLAST GROWTH FACTOR 2; HUMANS; IN SITU HYBRIDIZATION; INTERLEUKIN-8; LYMPHOKINES; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; MICROCIRCULATION; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; PROSTATIC NEOPLASMS; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, GROWTH FACTOR; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0032903649     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Folkman, J. What is the evidence that tumors are angiogenesis dependent? J. Natl. Cancer Inst. (Bethesda), 82: 4-6, 1989.
2. Folkman. J. How is blood vessel growth regulated in normal and neoplastic tissue? G.H.A. Clowes Memorial Award Lecture. Cancer Res., 46: 467-473, 1986.
3. Folkman, J., and Klagsbrun, M. Angiogenic factors. Science (Washington DC), 235: 442-447, 1992.
4. New, B., and Yeoman, L. Identification of basic fibroblast growth factor sensitivity and receptor and ligand expression in human colon tumor cell lines. J. Cell. Physiol., 150: 320-326, 1992.
5. Kim, K., Li, B., Winer, J., Armanini, M., Gillett, N., Philips, H., and Ferrara, N. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumor growth in vivo. Nature (Lond.), 362: 841-844, 1993.
6. Koch, A. E., Polverini, P. J., Kunkel, S. L., Harlow, L. A., DiPietro, L. A., Elner, V. M., Elner, S. G., and Strieter, R. M. Interleukin-8 as a macrophage-derived mediator of angiogenesis suppresses tumor growth in vivo. Science (Washington DC), 258: 1798-1801, 1992.
7. Chodak, G. W., Haundenschild, C., Gittes, R. F., and Folkman, J. Angiogenic activity as a marker of neoplastic and preneoplastic of the human bladder. Ann. Surg., 192: 762-771, 1980.
8. Weidner, N., Carroll, P. R., Flax, J., Blumfeld, W., and Folkman, J. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am. J. Pathol., 143: 401-409, 1993.
9. Bigler, S. A., Deering, R. E., and Brawer, M. A. Comparison of microscopic vascularity in benign and malignant prostate tissue. Hum. Pathol., 24: 220-226, 1993.
10. Liotta, L. A., Steeg, P. S., and Stetler-Stevenson, W. G. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell, 64: 327-336, 1991.
11. Folkman, J., and Sing, Y. Angiogenesis. J. Biol. Chem., 267: 10931-10934, 1992.
12. Blood, C. H., and Zetter, B. R. Tumor interactions with vasculature: angiogenesis and tumor metastasis. Biochim. Biophys. Acta, 1032: 89-118, 1990.
13. Harper, M. E., Glynne-Jones, E., Goddard, L., Thurston, V. J., and Griffiths, K. Vascular endothelial growth factor (VEGF) expression in prostatic tumours and its relationship to neuroendocrine cells. Br. J. Cancer, 74: 910-916, 1996.
14. Jackson, W. M., Bentel, J. M., and Tilley, W. D. Vascular endothelial growth factor (VEGF) in prostate cancer and benign prostatic hyperplasia. J. Urol., 157: 2323-2328, 1997.
15. Ferrer, F. A., Miller, L. J., Andrawis, R. I., Kurtzman, S. H., Albertsen, P. C., Laudone, V. P., and Kreutzer, D. L. Vascular endothelial growth factor (VEGF) expression in human prostate cancer: in situ and in vitro expression of VEGF by human prostate cancer cells. J. Urol., 157: 2329-2333, 1997.
16. Gridley, D. S., Andres, M. L., and Slater, J. M. Enhancement of prostate cancer xenograft growth with whole-body radiation and vascular endothelial growth factor. Anticancer Res., 17: 923-928, 1997.
17. Borgstrom, P., Bourdon. M. A., Hillan, K. J., Sriramarao, P., and Ferrara, N. Neutralizing anti-vascular endothelial growth factor anti-body completely inhibits angiogenesis and growth of human prostate carcinoma micro tumors in vivo. Prostate, 35: 1-10, 1998.
18. Joseph, I. B., and Isaacs, J. T. Potentiation of the antiangiogenic ability of llinomide by androgen ablation involves down-regulation of vascular endothelial growth factor in human androgen-responsive prostatic cancers. Cancer Res., 57: 1054-1057, 1997.
19. Stewart, R. J., and Folkman, J. Vascular endothelial growth factor is regulated by androgens in hormone-responsive human prostate carcinoma. J. Urol., 157 (Suppl. 4): 4, 1997.
20. Moon, W. C., Choi, H. R., and Moon, S. Y. Endocrine therapy inhibits expression of vascular endothelial growth factor and angiogenesis in prostate cancer. J. Urol., 157 (Suppl. 4): 223, 1997.
21. Pettaway, C. A., Pathak, S., Greene, G., Ramirez, E., Wilson, M. R., Killion, J. J., and Fidler, I. J. Selection of highly metastatic variants of different human prostatic carcinomas using orthotopic implantation in nude mice. Clin. Cancer Res., 2: 1627-1636, 1996.
22. Fort, P., Marty, L., Liechaczyk, M., Sabrouty, S. E., Dani, C., and Blanchard, J. M. Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate dehydrogenase multigene family. Nucleic Acids Res., 13: 1431-1442, 1985.
23. Rogelj, S., Weinberg, R. A., Fanning, P., and Klagsbrun, M. Basic fibroblast growth factor fused to a signal peptide transformed cells. Nature (Lond.), 331: 173-175, 1988.
24. Berse, B., Brown, L. F., Van der Walter, L., Dvorak, H. F., and Singer, D. R. Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages and tumors. Mol. Biol. Cell, 3: 211-220, 1992.
25. Matsushima, K., Morishita, K., Yoshimura, T., Lavu, S., Kobayashi, Y., Lew, W., Appela, E., Kung, H. F., Leonard, E. J., and Oppenheim, J. J. Molecular cloning of human monocyte-derived neutrophil chemotactic factor (MCNCF) and the induction of MDNCF mRNA by interleukin-1 and tumor necrosis factor. J. Exp. Med., 167: 1883-1893, 1988.
26. Weidner, N., Semple, J. P., Welch, W. R., and Folkman, J. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N. Engl. J. Med., 324: 1-8, 1991.
27. Pearson, W. R., and Lipman, D. J. Improved tools for biological sequence comparison. Proc. Natl. Acad. Sci. USA, 85: 2444-2448, 1988.
28. Caruthers, M. H., Beaucage, S. L., Efcavitch, J. W., Fisher, E. F., Goldman, R. A., DeHaseth, P. L., Mandecki, W., Matteucci, M. D., Rosendahl, M. S., and Sabintsky, Y. Chemical synthesis and biological studies on mutated gene-control regions. Cold Spring Harbor Symp. Quant. Biol., 47: 411-418, 1982.
29. Parks, C. S., Brigati, D. J., and Manahan, L. J. Automated molecular pathology: one-hour in situ DNA hybridization. J. Histotechnol., 14: 219-229, 1991.
30. Reed, J. A., Manahan, L. J., Park, C. S., and Brigati, D. J. Complete one-hour immunohistochemistry based on capillary action. BioTechniques, 13: 434-443, 1992.
31. Kitadai, Y., Ellis, L. M., Takahashi, Y., Bucana, C. D., Anzai, H., Tahara, E., and Fidler, I. J. Multiparametric in situ messenger RNA hybridization analysis to detect metastasis-related genes in surgical specimens of human colon carcinomas. Clin. Cancer Res., 1: 1095-1102, 1995.
32. Perrotte, P., Bielenberg, D. R., Eve, B. Y., and Dinney, C. P. Organ-specific angiogenesis and metastasis of human bladder carcinoma growing in athymic mice. Mol. Urol., 1: 299-307, 1997.
33. Brown, L. F., Berse, B., Jackmon, R. W., Tognazzi, K., Manseau, E. J., Senger, D. R., and Dvorak, H. F. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinoma of the gastrointestinal tract. Cancer Res., 53: 4727-4735, 1993.
34. Takahashi, A., Sasaki, H., Kim, S. J., Tobisu, K., Kakizoe, T., Tsukamoto, T., Kumamoto, Y., Sugimura, T., and Terada, M. Markedly increased amount of mRNAs for vascular endothelial growth factor and placental growth factor in renal cell carcinoma associated with angiogenesis. Cancer Res., 54: 4233-4237, 1994.
35. Takahashi, Y., Cleary, K. R., Mai, M., Kitadai, Y., Bucana, C. D., and Ellis, L. M. Significance of vessel count and vascular endothelial growth factor and its receptor (KDR) in intestinal-type gastric cancer. Clin. Cancer Res., 2: 1679-1684, 1996.
36. Houck, K. A., Leung, D. W., Rowland, A. M., Winer, J., and Ferrara, N. Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms. J. Biol. Chem., 267: 26031-26037, 1992.
37. Shweili, D., Itin, A., Soffer, D., and Keshet, E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature (Lond.), 359: 843-845, 1992.
38. Takano, S., Yoshii, Y., Kondo, S., Suzuki, H., Maruno, T., Shirai, S., and Nose, T. Concentration of vascular endothelial growth factor in the serum and tumor tissue of brain tumor patients. Cancer Res., 56: 2185-2190, 1996.
39. 3 integrin, osteopontin and thrombin. Am. J. Pathol., 149: 293-305, 1996.
40. Bikfalvi, A., Sauzeau, C., Moukadiri, H., Maclouf, J., Busso, N., Bryckaert, M., Plouet, J., and Tobelem, G. Interaction of vasculotropin/ vascular endothelial growth factor with human umbilical vein endothelial cells: binding, internalization, degradation and biological effects. J. Cell. Physiol., 149: 50-59, 1991.
41. Senger, D. R., van de Water, L., Brown, L. F., Nagy, J. A., Yeo, K. T., Berse, B., Jackman, R. W., Dvorak, A. M., and Dvorak, H. F. Vascular permeability factor (VPF, VEGF) in tumor biology. Cancer Metastasis Rev., 12: 303-324, 1993.
42. Brown, L. F., Berse, B., Jackman, R. W., Tognazzi, K., Manseau, E. J., Dvorak, H. F., and Senger, D. R. Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in kidney and bladder carcinomas. Am. J. Pathol., 143: 1255-1262, 1993.